Sort by
Exploring the Link between Interoception and Symptom Severity in Premature Ventricular Contractions
Alena S. Limonova,
Irina A. Minenko,
Anastasia A. Sukmanova,
Vladimir A. Kutsenko,
Sofya P. Kulikova,
Maria A. Nazarova,
Karapet Davtyan,
Oxana M. Drapkina,
Alexandra I. Ershova
Posted: 21 November 2024
Does Cryopreservation Negatively Affect Semen Parameters?Does Cryopreservation Negatively Affect Semen Parameters?
Anna Justyna Milewska,
Agnieszka Kuczyńska,
Michał Pawłowski,
Iwo Martynowicz,
Sebastian Deluga-Białowarczuk,
Piotr Sieczyński,
Waldemar Kuczyński,
Robert Milewski
Posted: 21 November 2024
Synergistic Potential of Antibiotics with Cancer Treatments
Giuseppe Nardo,
Pan Pantziarka,
Matteo Conti
Intratumoral microbiota, the diverse community of microorganisms residing within tumor tissues, represent an emerging and intriguing field in cancer biology. These microbial populations are distinct from the well-studied gut microbiota, offering novel insights into tumor biology, cancer progression, and potential therapeutic interventions. Recent studies have explored the use of certain antibiotics to modulate intratumoral microbiota and enhance the efficacy of cancer therapies, showing promising results. Antibiotics can alter intratumoral microbiota’s composition, which may have a major role in promoting cancer progression and immune evasion. Certain bacteria within tumors can promote immunosuppression and resistance to therapies. By targeting these bacteria, antibiotics can help create a more favorable environment for chemotherapy, targeted therapy and immunotherapy to act effectively. Some bacteria within the tumor microenvironment produce immunosuppressive molecules that inhibit the activity of immune cells. The combination of antibiotics and other cancer therapies holds significant promise for creating a synergistic effect and enhancing the immune response against cancer. In this review we analyze several preclinical studies that have been conducted to demonstrate the synergy between antibiotics and other cancer therapies and discuss possible clinical implications.
Intratumoral microbiota, the diverse community of microorganisms residing within tumor tissues, represent an emerging and intriguing field in cancer biology. These microbial populations are distinct from the well-studied gut microbiota, offering novel insights into tumor biology, cancer progression, and potential therapeutic interventions. Recent studies have explored the use of certain antibiotics to modulate intratumoral microbiota and enhance the efficacy of cancer therapies, showing promising results. Antibiotics can alter intratumoral microbiota’s composition, which may have a major role in promoting cancer progression and immune evasion. Certain bacteria within tumors can promote immunosuppression and resistance to therapies. By targeting these bacteria, antibiotics can help create a more favorable environment for chemotherapy, targeted therapy and immunotherapy to act effectively. Some bacteria within the tumor microenvironment produce immunosuppressive molecules that inhibit the activity of immune cells. The combination of antibiotics and other cancer therapies holds significant promise for creating a synergistic effect and enhancing the immune response against cancer. In this review we analyze several preclinical studies that have been conducted to demonstrate the synergy between antibiotics and other cancer therapies and discuss possible clinical implications.
Posted: 21 November 2024
Diabetes Mellitus: A Risk Factor in Schlemm’s Canal-Based MIGS
Etsuo Chihara,
Eri Nakano,
Tomoyuki Chihara
Objectives: To evaluate the impact of diabetes mellitus (DM) on the outcome of Schlemm’s canal based minimally invasive glaucoma surgery (MIGS). Methods: In a retrospective interventional cohort study, post- operative intraocular pressure (IOP) and intracameral bleeding were analyzed in 25 diabetic and 84 non-diabetic patients with primary open angle glaucoma (POAG) or ocular hypertension (OH). Results: The mean follow-up period for all 109 eyes was 35.3±24.8 months. There was no significant difference in pre-operative IOP between diabetic and non-diabetic cohorts. However, the post-surgical IOP between 3 months and 2 years was significantly higher in the diabetic cohort (P=0.019 to 0.001). The 3-year survival probability of achieving an IOP≦15 mmHg was 17.8±0.09% in diabetic patients, significantly lower than the 30.4±0.06% observed in non- diabetic patients (P=0.042 Log-rank test). The 3-year survival probability of achieving an IOP≦18 mmHg was 56.7±0.12% in diabetic patients compared to 79.5±0.05% in non-diabetic patients, indicating a marginally significant difference between diabetic and non-diabetic cohorts (P=0.065). When the random effect of diabetes mellitus (DM) was analyzed alongside the fixed effects of preoperative IOP, age, refractive error and extent of canal opening using a multivariate linear mixed model, DM emerged as a significant risk factor for higher postoperative IOP at both 6 and 12 months (P<0.001). Conclusions: Diabetes mellitus is a significant risk factor for poor outcomes following Schlemm’s canal based MIGS, particularly in achieving lower postoperative IOP.
Objectives: To evaluate the impact of diabetes mellitus (DM) on the outcome of Schlemm’s canal based minimally invasive glaucoma surgery (MIGS). Methods: In a retrospective interventional cohort study, post- operative intraocular pressure (IOP) and intracameral bleeding were analyzed in 25 diabetic and 84 non-diabetic patients with primary open angle glaucoma (POAG) or ocular hypertension (OH). Results: The mean follow-up period for all 109 eyes was 35.3±24.8 months. There was no significant difference in pre-operative IOP between diabetic and non-diabetic cohorts. However, the post-surgical IOP between 3 months and 2 years was significantly higher in the diabetic cohort (P=0.019 to 0.001). The 3-year survival probability of achieving an IOP≦15 mmHg was 17.8±0.09% in diabetic patients, significantly lower than the 30.4±0.06% observed in non- diabetic patients (P=0.042 Log-rank test). The 3-year survival probability of achieving an IOP≦18 mmHg was 56.7±0.12% in diabetic patients compared to 79.5±0.05% in non-diabetic patients, indicating a marginally significant difference between diabetic and non-diabetic cohorts (P=0.065). When the random effect of diabetes mellitus (DM) was analyzed alongside the fixed effects of preoperative IOP, age, refractive error and extent of canal opening using a multivariate linear mixed model, DM emerged as a significant risk factor for higher postoperative IOP at both 6 and 12 months (P<0.001). Conclusions: Diabetes mellitus is a significant risk factor for poor outcomes following Schlemm’s canal based MIGS, particularly in achieving lower postoperative IOP.
Posted: 21 November 2024
Differential Diagnosis and Rapid Clinical Resolution of a Neurological Case of Feline Infectious Peritonitis (FIP) Using GS441528
Huong (Amy) Huynh,
Pamela Moraguez,
Logan M Watkins,
Jonathan H. Wood,
Ximena A Olarte-Castillo,
Gary R. Whittaker
Posted: 21 November 2024
Medical Costs and Economic Impact of Hyperkalemia in a Cohort of Heart Failure Patients with Reduced Ejection Fraction
Andrea Lopez-López,
Margarita Regueiro-Abel,
Emilio Paredes-Galan,
Charigan Abou Johk-Casas,
Jose Maria Vietez-Florez,
Juliana Elices-Teja,
Jorge Armesto-Rivas,
Raúl Franco-Gutiérrez,
Ramón Rios-Vazquez,
Carlos González-Juanatey
Posted: 21 November 2024
Breed-associated Differences in Differential Gene Expression Following Immunotherapy-Based Treatment of Canine High-Grade Glioma
Susan A Arnold,
Walter C Low,
G. Elizabeth Pluhar
Posted: 21 November 2024
A One Health Perspective on the Resurgence of Flea-Borne Typhus in Texas in the 21st Century. Part 1. The Bacteria, The Cat Flea, Urbanization, and Climate Change
Gregory M Anstead
Posted: 21 November 2024
The Correlation Between Fibrosis-5 Index (Fib-5) and Fibrosis-4 Index (Fib-4) with the Duration of Heart Failure
Mohammadjavad Sotoudeheian
Aim: This study aimed to explore the correlation between the FIB-5 and FIB-4 indices, which assess liver fibrosis, and the grouped duration of heart failure (HF) in a cohort of subjects from the National Health and Nutrition Examination Survey (NHANES) 2015-2020. Methods: The study included 468 participants categorized into three groups based on HF duration: Group 1 (≤1 year, n=91), Group 2 (1-5 years, n=87), and Group 3 (>5 years, n=290). Data were analyzed using Pearson and Spearman correlation analyses to assess relationships between FIB-5, FIB-4, and HF duration. Clinical variables such as age, BMI, ALT, AST, albumin, and platelet count were also considered.Results: The analysis revealed significant correlation between FIB-5 with age (Pearson correlation (r) = -0.29, p<0.0001) but not for HF duration across groups (Spearman correlation (ρ) = -0.010, p=0.8217). The FIB-4 index did not show significant associations with the HF duration group (p=0.6326). The regression analysis also showed no significant predictive relationship between FIB-5 or FIB-4 and the duration of heart failure, further supporting the lack of association between fibrosis indices and HF duration in this cohort.Conclusion: The study found no significant correlation between the FIB-5 and FIB-4 indices and the duration of heart failure in this cohort. These findings suggest that while these fibrosis scores are useful in liver assessment, they may not directly reflect the duration of heart failure in this population. Further studies are needed to explore other potential biomarkers for HF duration.
Aim: This study aimed to explore the correlation between the FIB-5 and FIB-4 indices, which assess liver fibrosis, and the grouped duration of heart failure (HF) in a cohort of subjects from the National Health and Nutrition Examination Survey (NHANES) 2015-2020. Methods: The study included 468 participants categorized into three groups based on HF duration: Group 1 (≤1 year, n=91), Group 2 (1-5 years, n=87), and Group 3 (>5 years, n=290). Data were analyzed using Pearson and Spearman correlation analyses to assess relationships between FIB-5, FIB-4, and HF duration. Clinical variables such as age, BMI, ALT, AST, albumin, and platelet count were also considered.Results: The analysis revealed significant correlation between FIB-5 with age (Pearson correlation (r) = -0.29, p<0.0001) but not for HF duration across groups (Spearman correlation (ρ) = -0.010, p=0.8217). The FIB-4 index did not show significant associations with the HF duration group (p=0.6326). The regression analysis also showed no significant predictive relationship between FIB-5 or FIB-4 and the duration of heart failure, further supporting the lack of association between fibrosis indices and HF duration in this cohort.Conclusion: The study found no significant correlation between the FIB-5 and FIB-4 indices and the duration of heart failure in this cohort. These findings suggest that while these fibrosis scores are useful in liver assessment, they may not directly reflect the duration of heart failure in this population. Further studies are needed to explore other potential biomarkers for HF duration.
Posted: 21 November 2024
Spinal Specific Lexicon for Sentiment Analysis of Adult Spinal Deformity Patient Interviews Correlate with SRS22, SF36, and Odi Scores: A Pilot Study of 25 Patients
Ross Gore,
Michael M. Safaee,
Christopher J. Lynch,
Christopher P. Ames
Posted: 21 November 2024
of 1,351